Core Viewpoint - The legal opinion issued by Shanghai Jiahou Law Firm confirms that Hebei Jianxin Chemical Co., Ltd. has obtained the necessary approvals for the cancellation of stock options and the invalidation of restricted stocks under its 2022 stock option and restricted stock incentive plan, in accordance with relevant laws and regulations [1][11]. Group 1: Legal Framework and Compliance - The legal opinion is based on various laws including the Company Law, Securities Law, and regulations from the China Securities Regulatory Commission [1][2]. - The law firm conducted thorough verification of the facts and legal matters related to the cancellation and invalidation of stock options and restricted stocks [3][6]. - The company has ensured that all necessary approvals and authorizations for the adjustments to the incentive plan have been obtained, as per the management regulations and the incentive plan [8][11]. Group 2: Specifics of Cancellation and Invalidation - The company will cancel 1.7165 million stock options granted to 74 incentive targets and invalidate 2.04875 million restricted stocks granted to 23 incentive targets for the third assessment period [10][11]. - The performance targets for the third assessment period require a revenue increase of no less than 40% and a net profit increase of no less than 100% compared to 2021 [8][9]. - The actual performance for 2024 showed a revenue of approximately 605.38 million yuan and a net profit of approximately 17.16 million yuan, which did not meet the required targets [10].
建新股份: 上海嘉厚律师事务所关于建新股份2022年股票期权与限制性股票激励计划部分股票期权注销及部分限制性股票作废之法律意见书